Lishan Su

13PUBLICATIONS
60CO-AUTHORS
Haematological tumoursInnate immunityCardiology (incl. cardiovascular diseases)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 05, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

|Apr 02, 2026
Persistent IFN-I signaling inhibits mitochondrial oxidative metabolism in CD8<sup>+</sup> T cells during HIV-1 infection under cART.

Liang Cheng, Guangming Li, Fei Luo

|Mar 27, 2026
HEPLISAV-B Breaks Immune Tolerance and Induces HBV Control via CD4 T Cell-Dependent Mechanisms in a Chronic Hepatitis B Mouse Model.

James Ahodantin, Jiapeng Wu, Masaya Funaki

|Nov 05, 2025
Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8<sup>+</sup> T cells during chronic HIV-1 infection.

Guangming Li, Yaoxian Lou, Jianping Ma

|Aug 28, 2025
Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART.

Runpeng Han, Haisheng Yu, Guangming Li

|Sep 28, 2024
Advancing Human Vaccine Development Using Humanized Mouse Models.

Runpeng Han, Lishan Su, Liang Cheng

Pageof 3

Frequent Collaborators

3 joint publications

Haisheng Yu

3 joint publications

Runpeng Han

2 joint publications

Ourania Tsahouridis

2 joint publications

James Ahodantin